{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T21:47:56Z","timestamp":1775166476118,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-41467-6","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:56:25Z","timestamp":1772117785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between ultraviolet-related TP53 mutations and immune microenvironment in equine ocular squamous cell carcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Ginevra","family":"Martinoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"De Biase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Ressel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Avallone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Grillini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelangelo","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Sarli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Bacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"41467_CR1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/evj.12421","volume":"48","author":"EJ Knowles","year":"2016","unstructured":"Knowles, E. J., Tremaine, W. H., Pearson, G. R. & Mair, T. S. A database survey of equine tumours in the United Kingdom. Equine Vet. J. 48, 280\u2013284 (2016).","journal-title":"Equine Vet. J."},{"key":"41467_CR2","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1177\/03009858211022696","volume":"58","author":"G Tura","year":"2021","unstructured":"Tura, G. et al. Fibroblast-associated protein-\u03b1 expression and BPV nucleic acid distribution in equine sarcoids. Vet. Pathol. 58, 1044\u20131050 (2021).","journal-title":"Vet. Pathol."},{"key":"41467_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2460\/javma.242.1.99","volume":"242","author":"PA Schaffer","year":"2013","unstructured":"Schaffer, P. A., Wobeser, B., Martin, L. E. R., Dennis, M. M. & Duncan, C. G. Cutaneous neoplastic lesions of equids in the central United States and Canada: 3,351 biopsy specimens from 3,272 equids (2000\u20132010). J. Am. Vet. Med. Assoc. 242, 99\u2013104 (2013).","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"41467_CR4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.2460\/javma.1991.198.02.298","volume":"198","author":"SJ Dugan","year":"1991","unstructured":"Dugan, S. J., Roberts, S. M., Curtis, C. R. & Severin, G. A. Prognostic factors and survival of horses with ocular\/adnexal squamous cell carcinoma: 147 cases (1978\u20131988). J. Am. Vet. Med. Assoc. 198, 298\u2013303 (1991).","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"41467_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2460\/javma.1991.198.02.251","volume":"198","author":"SJ Dugan","year":"1991","unstructured":"Dugan, S. J., Roberts, S. M., Curtis, C. R. & Severin, G. A. Epidemiologic study of ocular\/adnexal squamous cell carcinoma in horses. J. Am. Vet. Med. Assoc. 198, 251\u2013256 (1991).","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"41467_CR6","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/eve.12185","volume":"26","author":"KW Montgomery","year":"2014","unstructured":"Montgomery, K. W. Equine ocular neoplasia: A review. Equine Vet. Educ. 26, 372\u2013380 (2014).","journal-title":"Equine Vet. Educ."},{"key":"41467_CR7","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1158\/1078-0432.CCR-14-1768","volume":"20","author":"CR Pickering","year":"2014","unstructured":"Pickering, C. R. et al. Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin. Cancer Res. 20, 6582\u20136592 (2014).","journal-title":"Clin. Cancer Res."},{"key":"41467_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/humu.10179","volume":"21","author":"G Giglia-Mari","year":"2003","unstructured":"Giglia-Mari, G. & Sarasin, A. TP53 mutations in human skin cancers. Hum. Mutat. 21, 217\u2013228 (2003).","journal-title":"Hum. Mutat."},{"key":"41467_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s42764-020-00009-8","volume":"1","author":"GP Pfeifer","year":"2020","unstructured":"Pfeifer, G. P. Mechanisms of UV-induced mutations and skin cancer. Genome Instab Dis. 1, 99\u2013113 (2020).","journal-title":"Genome Instab Dis."},{"key":"41467_CR10","doi-asserted-by":"publisher","unstructured":"Taneja, P. & C Solomon, M. HPV and head and neck cancer: A comprehensive review. Oral Oncol. Rep. 100451. https:\/\/doi.org\/10.1016\/j.oor.2024.100451 (2024).","DOI":"10.1016\/j.oor.2024.100451"},{"key":"41467_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11912-020-00938-3","volume":"22","author":"NE Wondergem","year":"2020","unstructured":"Wondergem, N. E., Nauta, I. H., Muijlwijk, T., Leemans, C. R. & van de Ven, R. The immune microenvironment in head and neck squamous cell carcinoma: On subsets and subsites. Curr. Oncol. Rep. 22, 81 (2020).","journal-title":"Curr. Oncol. Rep."},{"key":"41467_CR12","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s00262-020-02747-w","volume":"70","author":"F Succaria","year":"2021","unstructured":"Succaria, F. et al. Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas. Cancer Immunol. Immunother. 70, 1227\u20131237 (2021).","journal-title":"Cancer Immunol. Immunother"},{"key":"41467_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s13046-022-02481-4","volume":"41","author":"A Tosi","year":"2022","unstructured":"Tosi, A. et al. The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: A multiparametric quantitative and spatial analysis unveils a rationale to target treatment-na\u00efve tumors with immune checkpoint inhibitors. J. Exp. Clin. Cancer Res. 41, 279 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"41467_CR14","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3389\/fimmu.2018.01253","volume":"9","author":"SR Ottenhof","year":"2018","unstructured":"Ottenhof, S. R. et al. The prognostic value of immune factors in the tumor microenvironment of penile squamous cell carcinoma. Front. Immunol. 9, 1253. https:\/\/doi.org\/10.3389\/fimmu.2018.01253 (2018).","journal-title":"Front. Immunol."},{"key":"41467_CR15","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.7150\/jca.21444","volume":"8","author":"XJ Chen","year":"2017","unstructured":"Chen, X. J. et al. Clinical significance of CD163\u2009+\u2009and CD68\u2009+\u2009tumor-associated macrophages in high-risk HPV-related cervical cancer. J. Cancer. 8, 3868\u20133875 (2017).","journal-title":"J. Cancer"},{"key":"41467_CR16","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1177\/0300985810396516","volume":"48","author":"CG Knight","year":"2011","unstructured":"Knight, C. G., Munday, J. S., Peters, J. & Dunowska, M. Equine penile squamous cell carcinomas are associated with the presence of equine papillomavirus type 2 dna sequences. Vet. Pathol. 48, 1190\u20131194 (2011).","journal-title":"Vet. Pathol."},{"key":"41467_CR17","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1177\/0300985815583095","volume":"52","author":"KW Zhu","year":"2015","unstructured":"Zhu, K. W., Affolter, V. K., Gaynor, A. M., Dela Cruz, F. N. & Pesavento, P. A. Equine genital squamous cell carcinoma: In situ hybridization identifies a distinct subset containing Equus caballus Papillomavirus 2. Vet. Pathol. 52, 1067\u20131072 (2015).","journal-title":"Vet. Pathol."},{"key":"41467_CR18","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1177\/03009858251341544","volume":"62","author":"B Bacci","year":"2025","unstructured":"Bacci, B. et al. Immune cell analysis in equine penile papilloma, in situ squamous cell carcinoma and invasive squamous cell carcinoma: FoxP3\u2009+\u2009T regulatory lymphocytes differ according to equine papillomavirus 2 status. Vet. Pathol. 62, 902\u2013912 (2025).","journal-title":"Vet. Pathol."},{"key":"41467_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.tvjl.2017.05.007","volume":"223","author":"S Sykora","year":"2017","unstructured":"Sykora, S. & Brandt, S. Papillomavirus infection and squamous cell carcinoma in horses. Vet. J. 223, 48\u201354 (2017).","journal-title":"Vet. J."},{"key":"41467_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/evj.13116","volume":"52","author":"KE Knickelbein","year":"2020","unstructured":"Knickelbein, K. E. et al. R. A missense mutation in damage-specific DNA binding protein 2 is a genetic risk factor for ocular squamous cell carcinoma in Belgian horses. Equine Vet. J. 52, 34\u201340 (2020).","journal-title":"Equine Vet. J."},{"key":"41467_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3390\/pathogens12020179","volume":"12","author":"L Miglinci","year":"2023","unstructured":"Miglinci, L. et al. Detection of equine papillomaviruses and gamma-herpesviruses in equine squamous cell carcinoma. Pathogens 12, 179. https:\/\/doi.org\/10.3390\/pathogens12020179 (2023).","journal-title":"Pathogens"},{"key":"41467_CR22","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/evj.12245","volume":"47","author":"JGB van den Top","year":"2015","unstructured":"van den Top, J. G. B. et al. Expression of p53, Ki67, EcPV2- and EcPV3 DNA, and viral genes in relation to metastasis and outcome in equine penile and preputial squamous cell carcinoma. Equine Vet. J. 47, 188\u2013195 (2015).","journal-title":"Equine Vet. J."},{"key":"41467_CR23","doi-asserted-by":"crossref","unstructured":"Brunetti, B. et al. Validation of p53 immunohistochemistry (PAb240 clone) in canine tumors with next-generation sequencing (NGS) analysis. Animals 13 (2023).","DOI":"10.3390\/ani13050899"},{"key":"41467_CR24","doi-asserted-by":"publisher","first-page":"14087","DOI":"10.1038\/s41598-024-64963-z","volume":"14","author":"LV Muscatello","year":"2024","unstructured":"Muscatello, L. V. et al. Analysis of MDM2 and TP53 genes in canine liposarcoma. Sci. Rep. 14, 14087. https:\/\/doi.org\/10.1038\/s41598-024-64963-z (2024).","journal-title":"Sci. Rep."},{"key":"41467_CR25","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.3390\/genes11121460","volume":"11","author":"M Crausaz","year":"2020","unstructured":"Crausaz, M. et al. DDB2 genetic risk factor for ocular squamous cell carcinoma identified in three additional horse breeds. Genes (Basel). 11, 1460. https:\/\/doi.org\/10.3390\/genes11121460 (2020).","journal-title":"Genes (Basel)"},{"key":"41467_CR26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/ijc.30744","volume":"141","author":"RR Bellone","year":"2017","unstructured":"Bellone, R. R. et al. A missense mutation in damage-specific DNA binding protein 2 is a genetic risk factor for limbal squamous cell carcinoma in horses. Int. J. Cancer. 141, 342\u2013353 (2017).","journal-title":"Int. J. Cancer"},{"key":"41467_CR27","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.3390\/cancers16162904","volume":"16","author":"TM Hosseini","year":"2024","unstructured":"Hosseini, T. M. et al. The mutational and microenvironmental landscape of cutaneous squamous cell carcinoma: A review. Cancers (Basel). 16, 2904. https:\/\/doi.org\/10.3390\/cancers16162904 (2024).","journal-title":"Cancers (Basel)"},{"key":"41467_CR28","doi-asserted-by":"crossref","unstructured":"Brash, D. E. et al. J. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl Acad. Sci. USA 88, 10124\u201310128 (1991).","DOI":"10.1073\/pnas.88.22.10124"},{"key":"41467_CR29","doi-asserted-by":"crossref","unstructured":"Ziegler, A. et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc. Natl Acad. Sci. USA 90, 4216\u20134220 (1993).","DOI":"10.1073\/pnas.90.9.4216"},{"key":"41467_CR30","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/cdd.2017.180","volume":"25","author":"EH augh","year":"2018","unstructured":"augh, E. H., Ke, H., Levine, A. J., Bonneau, R. A. & Chan, C. S. Why are there hotspot mutations in the TP53 gene in human cancers? Cell. Death Differ. 25, 154\u2013160 (2018).","journal-title":"Cell. Death Differ."},{"key":"41467_CR31","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1177\/1040638718770239","volume":"30","author":"DS Russell","year":"2018","unstructured":"Russell, D. S., Jaworski, L. & Kisseberth, W. C. Immunohistochemical detection of p53, PTEN, Rb, and p16 in canine osteosarcoma using tissue microarray. J. Vet. Diagn. Invest. 30, 504\u2013509 (2018).","journal-title":"J. Vet. Diagn. Invest."},{"key":"41467_CR32","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.237453","author":"J Blagih","year":"2020","unstructured":"Blagih, J. et al. p53, cancer and the immune response. J. Cell. Sci. 133. https:\/\/doi.org\/10.1242\/jcs.237453 (2020).","journal-title":"J. Cell. Sci."},{"key":"41467_CR33","doi-asserted-by":"crossref","unstructured":"Tessier-Cloutier, B. et al. Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status. Mod. Pathol. 33, 1595\u20131605 (2020).","DOI":"10.1038\/s41379-020-0524-1"},{"key":"41467_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.tvjl.2017.04.014","volume":"225","author":"S Sykora","year":"2017","unstructured":"Sykora, S., Jindra, C., Hofer, M., Steinborn, R. & Brandt, S. Equine papillomavirus type 2: An equine equivalent to human papillomavirus 16? Vet. J. 225, 3\u20138 (2017).","journal-title":"Vet. J."},{"key":"41467_CR35","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41379-019-0350-5","volume":"33","author":"H Griffin","year":"2020","unstructured":"Griffin, H. et al. Human papillomavirus type 16 causes a defined subset of conjunctival in situ squamous cell carcinomas. Mod. Pathol. 33, 74\u201390 (2020).","journal-title":"Mod. Pathol."},{"key":"41467_CR36","doi-asserted-by":"publisher","first-page":"e1342","DOI":"10.1002\/vms3.1342","volume":"10","author":"L Tuomisto","year":"2024","unstructured":"Tuomisto, L. et al. Equus caballus papillomavirus type 2 (EcPV2)-associated benign penile lesions and squamous cell carcinomas. Vet. Med. Sci. 10, e1342. https:\/\/doi.org\/10.1002\/vms3.1342 (2024).","journal-title":"Vet. Med. Sci."},{"key":"41467_CR37","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1177\/0300985820941266","volume":"57","author":"S Greenwood","year":"2020","unstructured":"Greenwood, S. et al. Prevalence and prognostic impact of Equus caballus papillomavirus type 2 infection in equine squamous cell carcinomas in western Canadian horses. Vet. Pathol. 57, 623\u2013631 (2020).","journal-title":"Vet. Pathol."},{"key":"41467_CR38","doi-asserted-by":"crossref","unstructured":"Powell, E., Piwnica-Worms, D. & Piwnica-Worms, H. Contribution of p53 to metastasis. Cancer Discov. 4, 405\u2013414 (2014).","DOI":"10.1158\/2159-8290.CD-13-0136"},{"key":"41467_CR39","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1158\/1078-0432.CCR-18-1749","volume":"25","author":"SJ Santegoets","year":"2019","unstructured":"Santegoets, S. J. et al. The anatomical location shapes the immune infiltrate in tumors of same etiology and affects survival. Clin. Cancer Res. 25, 240\u2013252 (2019).","journal-title":"Clin. Cancer Res."},{"key":"41467_CR40","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 16878. https:\/\/doi.org\/10.1038\/s41598-017-17204-5 (2017).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41467-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41467-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41467-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T21:01:48Z","timestamp":1775163708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41467-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["41467"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-41467-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"8 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11151"}}